健保藥品HTA評估報告
| 序號 | 標題 | 檔案類型 |
|---|---|---|
| 1 | 愛可穩錠 50 毫克 (Equfina Tablets 50 mg) |
|
| 2 | Taigexyn Infusion Solution 500 mg/250 ml |
|
| 3 | Const-K Extended-Release Tablets 750 mg |
|
| 4 | CRRT non Ca dialysate |
|
| 5 | Tecentriq 1200 mg/ 20 mL |
|
| 6 | Takhzyro solution for injection |
|
| 7 | 瑞多寧緩釋膠囊 (Numient extended-release capsules) |
|
| 8 | Nubeqa film-coated tablets 300 mg |
|
| 9 | 維泰凱 (Vitrakvi) |
|
| 10 | Vosevi Film-Coated Tablets |
|
| 11 | Vyzulta 0.024%, Solution |
|
| 12 | 羅思克 200 毫克膠囊 (Rozlytrek 200mg hard capsules) |
|
| 13 | Rinvoq Extended-Release Tablets 15 mg |
|
| 14 | 益穩挺注射液 (Evenity Solution for Injection) |
|
| 15 | Ajovy |
|
| 16 | Enerzair Breezhaler |
|
| 17 | Briviact Solution for Injection 10mg/ml |
|
| 18 | Ongentys |
|
| 19 | Vancover Capsules |
|
| 20 | 顛控達 0.5毫克/毫升口服懸液劑（Fycompa® 0.5 mg/ml oral suspension） |
|